Literature DB >> 2845648

The functional domains of the phosphoprotein (NS) of vesicular stomatitis virus (Indiana serotype).

P R Paul1, D Chattopadhyay, A K Banerjee.   

Abstract

A full-length cDNA clone of the mRNA encoding the phosphoprotein (NS) of the Indiana serotype of vesicular stomatitis virus was inserted into the SP6 transcription vector. By in vitro transcription of the inserted gene followed by translation of the mRNA in a rabbit reticulocyte lysate, NS protein was synthesized. The biological activity of the protein was demonstrated by RNA synthesis in vitro by reconstitution with L protein and N-RNA template purified from virions. Using oligonucleotide-directed RNase H cleavage of the full-length NS mRNA, a series of deleted RNAs were made which gave rise to corresponding size classes of truncated NS protein after translation in vitro. The N-RNA template binding site was located at the C-terminal domain (21 amino acids) of the NS protein and the L-protein binding site was present within 14 amino acids spanning the NH2-terminal side of the N-RNA binding site. These results are similar to that obtained with the NS protein of the New Jersey serotype of VSV, indicating conservation of the functional domains within the VSV serotypes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845648     DOI: 10.1016/0042-6822(88)90505-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro.

Authors:  A M Takacs; S Barik; T Das; A K Banerjee
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Crystal structure of the oligomerization domain of the phosphoprotein of vesicular stomatitis virus.

Authors:  Haitao Ding; Todd J Green; Shanyun Lu; Ming Luo
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein.

Authors:  P Staeheli; J Pavlovic
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor, P.

Authors:  Todd J Green; Ming Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

5.  Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation.

Authors:  Ryan Abdella; Megha Aggarwal; Takashi Okura; Robert A Lamb; Yuan He
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

6.  A novel fish rhabdovirus from sweden is closely related to the Finnish rhabdovirus 903/87.

Authors:  Tove Johansson; Lillemor Ostman-Myllyoja; Anders Hellström; Suzanne Martelius; Niels Jørgen Olesen; Harry Björklund
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

7.  Role of the hypervariable hinge region of phosphoprotein P of vesicular stomatitis virus in viral RNA synthesis and assembly of infectious virus particles.

Authors:  Subash C Das; Asit K Pattnaik
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Cooperative binding of multimeric phosphoprotein (P) of vesicular stomatitis virus to polymerase (L) and template: pathways of assembly.

Authors:  Y Gao; J Lenard
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Optimal replication activity of vesicular stomatitis virus RNA polymerase requires phosphorylation of a residue(s) at carboxy-terminal domain II of its accessory subunit, phosphoprotein P.

Authors:  L N Hwang; N Englund; T Das; A K Banerjee; A K Pattnaik
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

10.  Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: analysis of phosphorylation status versus transcriptional activity.

Authors:  S Barik; A K Banerjee
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.